Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Cancer Immunology Research|November 4, 2018
Of Microbes and MicrosatellitesChloe E Atreya, Alan P Venook
JCO Precision Oncology|July 10, 2025
Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision DosingDaniel L Hertz, Alan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gainKatherine Van Loon, Alan P Venook
Current Oncology Reports|September 4, 2008
The impact of new data in the treatment of advanced hepatocellular carcinomaGhassan K Abou-Alfa, Alan P Venook
The Lancet. Oncology|June 4, 2013
The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?Ghassan K Abou-Alfa, Alan P Venook
Chinese Clinical Oncology|April 6, 2015
A review of hepatocellular carcinoma (HCC) staging systemsSomasundaram Subramaniam, Robin K Kelley, Alan P Venook
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 6, 2012
Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trialRobin K Kelley, Ryutaro Hirose, Alan P Venook
Journal of Biopharmaceutical Statistics|April 23, 2009
Design issues in dose-finding Phase I trials for combinations of two agentsShenghua Kelly Fan, Alan P Venook, Ying Lu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Predictive biomarkers for bevacizumab: are we there yet?Dipen Maru, Alan P Venook, Lee M Ellis
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
On the Verge: Immunotherapy for Colorectal CarcinomaDavid Y Oh, Alan P Venook, Lawrence Fong
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Cancer Immunology Research|November 4, 2018
Of Microbes and MicrosatellitesChloe E Atreya, Alan P Venook
JCO Precision Oncology|July 10, 2025
Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision DosingDaniel L Hertz, Alan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gainKatherine Van Loon, Alan P Venook
Current Oncology Reports|September 4, 2008
The impact of new data in the treatment of advanced hepatocellular carcinomaGhassan K Abou-Alfa, Alan P Venook
The Lancet. Oncology|June 4, 2013
The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?Ghassan K Abou-Alfa, Alan P Venook
Chinese Clinical Oncology|April 6, 2015
A review of hepatocellular carcinoma (HCC) staging systemsSomasundaram Subramaniam, Robin K Kelley, Alan P Venook
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 6, 2012
Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trialRobin K Kelley, Ryutaro Hirose, Alan P Venook
Journal of Biopharmaceutical Statistics|April 23, 2009
Design issues in dose-finding Phase I trials for combinations of two agentsShenghua Kelly Fan, Alan P Venook, Ying Lu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Predictive biomarkers for bevacizumab: are we there yet?Dipen Maru, Alan P Venook, Lee M Ellis
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
On the Verge: Immunotherapy for Colorectal CarcinomaDavid Y Oh, Alan P Venook, Lawrence Fong
Pageof 25